Use of radiation in extramedullary leukemia/chloroma: Guidelines from the International Lymphoma Radiation Oncology Group Journal Article


Authors: Bakst, R. L.; Dabaja, B. S.; Specht, L. K.; Yahalom, J.
Article Title: Use of radiation in extramedullary leukemia/chloroma: Guidelines from the International Lymphoma Radiation Oncology Group
Abstract: Survival times for patients with leukemia generally have improved in recent decades, and this improvement has been attributed to an enhanced understanding of the genetics driving the cause of the disease and improved combinations of chemotherapy and targeted therapy. Durable control of systemic disease in blood and bone marrow has significantly improved survival, but extramedullary relapse can pose therapeutic challenges for which radiation therapy can have an important role. This report discusses the current role of radiation therapy for patients with leukemia, specifically the extramedullary manifestations of leukemia. © 2018
Keywords: chemotherapy; bone marrow; radiotherapy; oncology; survival time; radiation oncology; disease control; diseases; systemic disease; extramedullary leukemias
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 102
Issue: 2
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2018-10-01
Start Page: 314
End Page: 319
Language: English
DOI: 10.1016/j.ijrobp.2018.05.045
PROVIDER: scopus
PUBMED: 30191865
DOI/URL:
Notes: Review -- Export Date: 1 October 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Joachim Yahalom
    634 Yahalom